Laboratory safety of long-term dupilumab treatment in a 5-year open-label extension study of adults with moderate-to-severe atopic dermatitis

L. A. Beck,R. Bissonnette,M. Deleuran,T. Nakahara, R. Galus,F. A. Khokhar, A. Coleman, G. Gherardi,Z. Chen, E. Avetisova, A. Dubost-Brama, A. Shabbir

Journal of Investigative Dermatology(2023)

引用 0|浏览1
暂无评分
关键词
atopic dermatitis,treatment,long-term,open-label,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要